EFB Dengue Literature Review

T-bet

8 min read

T-bet

Overview

T-bet (encoded by TBX21) is a T-box transcription factor originally identified as the master regulator of Th1 CD4⁺ T cell differentiation. In B cells, T-bet marks a cluster referred to by several overlapping (but non-identical) labels — age-associated B cells (ABCs), atypical B cells, or DN2 B cells — depending on disease context and the surface markers used; these labels intersect rather than coincide (see Atypical B Cell for the synonymy map). T-bet cooperates with ZEB2 to promote effector cell differentiation through inhibition of TCF7 (a TF critical for central memory fate), and its expression is induced by TLR7 signalling and IFN-γ.

Key Points from Literature

  • Highest expression in DN2 and aNAV cells: T-bet (TBX21) RNA and protein expression is highest in DN2 and aNAV cells, significantly above rNAV, SWM, DN1, and even PC (p<0.001 for all pairwise comparisons by flow cytometry MFI). DN2 and aNAV are the main depository of CD11c^hi T-bet^hi human B cells (see Jenks2018 - DN2 B Cells and EF Pathway in SLE, RNA-seq + flow cytometry n=4).

  • T-bet/ZEB2 cooperation: T-bet induces ZEB2, and the two cooperate to promote effector cell differentiation (analogous to their role in CD8⁺ T cell terminal differentiation, citing Dominguez et al. 2015). In DN2 cells, T-bet and ZEB2 are both highly expressed while TCF7 (the central memory TF they repress) is absent. DN1 and SWM cells express TCF7 but not T-bet, consistent with a central memory or GC-derived identity (see Jenks2018 - DN2 B Cells and EF Pathway in SLE).

  • T-bet induced by TLR7 + IFN-γ in vitro: rNAV cells stimulated with R848 + IFN-γ + IL-21 upregulate T-bet as they differentiate into aNAV and DN2 cells. In vitro-generated DN2 cells are CD23⁻ T-bet⁺ (see Jenks2018 - DN2 B Cells and EF Pathway in SLE).

  • Murine parallel: Murine CD11c^bright ABCs are T-bet-dependent and drive anti-viral IgG2a and lupus-like autoimmunity in a TLR7-mediated fashion. B cells expressing T-bet localise to the T-B cell border (extrafollicular zone) and drive autoimmunity (citing Rubtsova et al. 2017). SLE DN2 cells share this T-bet⁺ CD11c^bright phenotype (see Jenks2018 - DN2 B Cells and EF Pathway in SLE).

  • FOXO1 absent: FOXO1, a known T-bet repressor, is not expressed in DN2 or aNAV cells — releasing T-bet from transcriptional inhibition (see Jenks2018 - DN2 B Cells and EF Pathway in SLE).

  • T-bet is important but not absolutely required for ABC: CD11c⁺ B cells can be generated and maintained in the absence of T-bet. ABC markers including CD11c can be induced in vitro through diverse activation conditions without IFN-γ stimulation or T-bet expression. T-bet deficiency in humans confirms a central role but does not abolish all ABC (see Sanz2025 - Human Atypical B Cells Overview, review citing Yang et al. 2022, Du et al. 2019).

  • Autoregulatory TBX21 locus: The TBX21 locus contains an upstream distal element that is bound by T-bet itself, suggesting autoregulatory positive feedback. These features are present in both SLE and healthy DN2 cells (see Sanz2025 - Human Atypical B Cells Overview, review).

  • T-bet⁺/FcRL5⁺ vs. T-bet⁻/FcRL5⁻ memory partition: Within CD27⁺ memory, T-bet⁺/FcRL5⁺ memory ABC cells are poised for ASC differentiation and correlate with long-lived antibody responses. T-bet⁻/FcRL5⁻ canonical memory cells retain stem-like central memory properties (see Sanz2025 - Human Atypical B Cells Overview, review citing Nellore et al. 2023).

  • T-bet expression validated in acute COVID-19 by intracellular staining: Intracellular T-bet staining in ICU-C patients (n=4) confirmed that aN and DN2 cells express the highest T-bet levels (MFI) of any B cell subset — above rN, DN1, and DN3. This validates in an infection context the T-bet hierarchy previously established in SLE (see Woodruff2020 - EF B Cell Responses in COVID-19, spectral FCM + intracellular staining).

  • T-bet expression mapped on UMAP: T-bet expression overlaid on composite UMAP projections cleanly colocalised with the aN/DN2 region (cluster 2, ROI 1), distinguishing the EF pathway populations from naive, memory, and ASC clusters (see Woodruff2020 - EF B Cell Responses in COVID-19, Fig. 2e).

  • T-BET motifs are the top enriched motifs in DN2 accessible chromatin: ATAC-seq motif analysis showed T-BET binding motifs as the most enriched in DN2-specific DARs (vs. switched memory). T-BET, together with AP-1 and EGR, constituted the core DN2 motif signature — distinct from NF-κB, EBF, and OCT motifs enriched in switched memory (see Scharer2019 - Epigenetic Programming in SLE B Cells, ATAC-seq motif enrichment, n=9 SLE + n=12 HC).

  • T-BET chromatin programme is shared by HC and SLE DN2 cells — not disease-specific: The T-BET motif enrichment in DN2 accessible chromatin was present in both healthy controls and SLE, confirming that T-BET-driven programming is a normal feature of the DN2 differentiation state rather than an SLE-specific aberration. The disease-specific layer is AP-1/EGR amplification on top of the normal T-BET programme (see Scharer2019 - Epigenetic Programming in SLE B Cells).

  • T-BET autoregulatory loop confirmed by ChIP-seq: ENCODE ChIP-seq data showed T-BET binding at an upstream distal element of its own TBX21 locus, with enhanced chromatin accessibility at this element in both aN and DN2 cells. This confirms the autoregulatory positive feedback suggested by Sanz2025 (see Scharer2019 - Epigenetic Programming in SLE B Cells, ATAC-seq + ENCODE ChIP-seq from GM12878 B cells).

  • T-BET binding confirmed at key DN2 marker genes: T-BET ChIP-seq peaks mapped to accessible chromatin at GAS7, TNFRSF1B, ITGAX (CD11c), ZAP70, and TBX21 loci — all in regions specifically accessible in aN and DN2 cells (see Scharer2019 - Epigenetic Programming in SLE B Cells).

  • T-bet⁺ CD4⁺ T cell expansion in COVID-19 lymphoid tissue — TH1 skewing at the anatomical level: Multi-color immunofluorescence of post-mortem COVID-19 lymph nodes and spleens showed T-bet⁺ CD4⁺ T cells consistently increased in both organs, in both early and late disease. TH2 (GATA-3⁺) decreased; TH17 (RORγt⁺) variably increased. This TH1 skewing at the tissue level is consistent with the TNF-α-mediated GC TFH block — T-bet expression in CD4⁺ T cells is associated with IFN-γ and TNF-α production, which may suppress Bcl-6 expression required for GC-TFH differentiation (see Kaneko2020 - GC Loss and TFH Block in COVID-19, n=11 COVID + controls, multi-color immunofluorescence).

  • T-bet expected but not directly stained in acute dengue: CD21⁻CD11c⁺ B cells within the IgD⁻CD27⁻ gate are significantly expanded during acute dengue — a phenotype consistent with T-bet⁺ DN2 identity based on the Jenks2018, Woodruff2020, and Scharer2019 characterisations. However, T-bet was not directly stained in this study. Formal confirmation of T-bet expression on dengue EF B cells remains outstanding and is the single most important pending phenotypic validation (see Ansari2025 - Peripheral T Helper Subset Drives B Cell Response in Dengue, n=170 acute dengue, multi-color FCM without intracellular T-bet).

  • TBX21 (T-bet) defines the alternative B cell lineage at the transcriptomic level: scRNA-seq of >12,000 B cells placed TBX21 expression as one of three core genes (alongside ITGAX/CD11c and FCRL5) defining the alternative lineage. T-bet expression was consistent across all alternative lineage clusters (atBC1, atBC2, atBC3, MBC1) and absent from the classical lineage (MBC2, MBC3, actBC), confirming T-bet as a lineage-defining rather than activation-state marker in this framework (see Sutton2021 - Alternative Lineage B Cells in Vaccination and Infection, n=4, 10x Chromium scRNA-seq).

  • T-bet is the defining transcription factor of the ABC population — and IFN-γ is its primary inducer. ABCs were defined by T-bet from their first description (CD19⁺CD21⁻CD23⁻T-bet⁺CD11c⁺ in aged mice); in the ABC differentiation programme IFN-γ primarily promotes T-bet while IL-21 induces CD11c. In autoimmunity, elevated T-bet in B cells drives increased antibody production, antigen presentation, and even germinal-center formation (see Lamprinou2026 - ABCs and DN B Cells, opinion, citing Hao 2011 / Naradikian 2016 / Liu 2024 / Rubtsov 2017).

  • T-bet is the marker that separates DN2 from the other DN subsets. Among the DN subsets (DN1–DN4), DN2 is the only one that highly expresses T-bet; DN1 and DN4 are T-bet⁻ and DN3 is T-bet^low. T-bet is thus the single axis that aligns DN2 with the ABC/atypical cluster while excluding the CXCR5⁺ DN subsets (see Lamprinou2026 - ABCs and DN B Cells, opinion; Double-Negative B Cell).

Contradictions & Debates

None documented in current wiki sources.

DN2 B Cell, Age-Associated B Cell, Atypical B Cell, Activated Naive B Cell, ZEB2, Double-Negative B Cell, CD11c, TLR7, IL-21, Extrafollicular Response, FCRL5, CXCR3, ATF3, EGR, Peripheral Helper T Cell

Sources

Graph View

Backlinks